First Turn Management, LLC

Position in ASND — Ascendis Pharma A/S

CIK 1993440 DEL MAR, CA

Position in ASND

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$17,452,099

-$10,654,638 QoQ

Shares Held

76,300

-42.1% QoQ

Ownership

0.116%

of shares outstanding

% of Portfolio

1.95%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

10 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

First Turn Management, LLC holds $816,783,749 across 31 Biotechnology names. ASND ranks #23 (2.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABVX	Abivax S.A.	465,869	$51,874,513
2	BBIO	BridgeBio Pharma, Inc.	695,718	$51,664,018
3	XENE	Xenon Pharmaceuticals Inc.	786,844	$45,754,978
4	RVMD	Revolution Medicines, Inc.	468,376	$45,549,566
5	APGE	Apogee Therapeutics, Inc.	513,770	$43,244,020
6	INSM	INSMED Inc	248,475	$40,630,632
7	NUVL	Nuvalent, Inc.	370,344	$37,941,742
8	MIRM	Mirum Pharmaceuticals, Inc.	400,464	$36,994,864

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$17,452,099	76,300	-42.1%	Shares	Sole	2026-05-15
2025-12-31	$28,106,737	131,808	-9.9%	Shares	Sole	2026-02-13
2025-09-30	$29,084,113	146,291	+8.6%	Shares	Sole	2025-11-14
2025-06-30	$23,246,976	134,687	+18.9%	Shares	Sole	2025-08-14
2025-03-31	$17,655,509	113,278	+29.0%	Shares	Sole	2025-05-15
2024-12-31	$12,087,976	87,804	-41.7%	Shares	Sole	2025-02-14
2024-09-30	$22,485,040	150,593	-19.3%	Shares	Sole	2024-11-07
2024-06-30	$25,445,916	186,581	+23.1%	Shares	Sole	2024-08-08
2024-03-31	$22,915,406	151,587	0.0%	Shares	Sole	2024-05-06
2023-12-31	$19,092,382	151,587	—	Shares	Sole	2024-02-08
No filing history on record for this holder in this stock.